ArticleJournal of arrhythmia2020

Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA-AF-Japan): One-year safety and effectiveness analyses.

Takeshi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.